Header Logo

Connection

NEAL KLEIMAN to Oligonucleotides

Back to Details
This is a "connection" page, showing publications NEAL KLEIMAN has written about Oligonucleotides.
NEAL KLEIMAN
Connection Strength
0.075
Oligonucleotides
  1. Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease. Circulation. 2008 Jun 03; 117(22):2865-74.
    View in: PubMed
    Score: 0.075
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.